Agilent Technologies Long Term Debt 2010-2025 | A

Agilent Technologies long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
  • Agilent Technologies long term debt for the quarter ending January 31, 2025 was $3.347B, a 31% increase year-over-year.
  • Agilent Technologies long term debt for 2024 was $3.345B, a 22.3% increase from 2023.
  • Agilent Technologies long term debt for 2023 was $2.735B, a 0.07% increase from 2022.
  • Agilent Technologies long term debt for 2022 was $2.733B, a 0.15% increase from 2021.
Agilent Technologies Annual Long Term Debt
(Millions of US $)
2024 $3,345
2023 $2,735
2022 $2,733
2021 $2,729
2020 $2,284
2019 $1,791
2018 $1,799
2017 $1,801
2016 $1,904
2015 $1,655
2014 $1,663
2013 $2,699
2012 $2,112
2011 $1,932
2010 $2,190
2009 $2,904
Agilent Technologies Quarterly Long Term Debt
(Millions of US $)
2025-01-31 $3,347
2024-10-31 $3,345
2024-07-31 $2,137
2024-04-30 $2,136
2024-01-31 $2,555
2023-10-31 $2,735
2023-07-31 $2,734
2023-04-30 $2,733
2023-01-31 $2,733
2022-10-31 $2,733
2022-07-31 $2,732
2022-04-30 $2,730
2022-01-31 $2,730
2021-10-31 $2,729
2021-07-31 $2,728
2021-04-30 $2,727
2021-01-31 $2,185
2020-10-31 $2,284
2020-07-31 $2,283
2020-04-30 $1,788
2020-01-31 $1,787
2019-10-31 $1,791
2019-07-31 $1,294
2019-04-30 $1,798
2019-01-31 $1,798
2018-10-31 $1,799
2018-07-31 $1,799
2018-04-30 $1,800
2018-01-31 $1,800
2017-10-31 $1,801
2017-07-31 $1,801
2017-04-30 $1,802
2017-01-31 $1,802
2016-10-31 $1,904
2016-07-31 $1,652
2016-04-30 $1,654
2016-01-31 $1,653
2015-10-31 $1,655
2015-07-31 $1,655
2015-04-30 $1,656
2015-01-31 $1,658
2014-10-31 $1,663
2014-07-31 $2,181
2014-04-30 $2,693
2014-01-31 $2,695
2013-10-31 $2,699
2013-07-31 $2,701
2013-04-30 $2,106
2013-01-31 $2,111
2012-10-31 $2,112
2012-07-31 $1,714
2012-04-30 $1,926
2012-01-31 $1,929
2011-10-31 $1,932
2011-07-31 $2,168
2011-04-30 $2,144
2011-01-31 $2,138
2010-10-31 $2,190
2010-07-31 $2,177
2010-04-30 $1,393
2010-01-31 $1,410
2009-10-31 $2,904
2009-07-31 $2,153
2009-04-30 $2,154
2009-01-31 $2,154
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $33.351B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.058B 28.41
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
ResMed (RMD) United States $32.876B 25.32
Terumo (TRUMY) Japan $27.805B 39.54
Koninklijke Philips (PHG) Netherlands $23.874B 17.05
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Baxter (BAX) United States $17.557B 12.63
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AtriCure (ATRC) United States $1.577B 0.00
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.087B 12.18
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00